Building and maintaining an in-house regulatory affairs function has become one of the more expensive, hard-to-staff overheads in pharma, biotech, and medical devices — and more companies are deciding it isn't worth carrying alone. According to Polaris Market Research, the global regulatory affairs outsourcing market was valued at USD 6.66 billion in 2023 and is projected to reach USD...
